+
Site Tour

EuroEcho 2021: Advances to optimize tricuspid regurgitation management: the evidence

Maurizio Taramasso presents on the clinical and real-world outcomes from the TRILUMINATE trial and TriClip™ bRIGHT study, respectively.

Related Videos

M-TEER: patient selection and current evidence

Navitor™: Voice of the Experts Mohammed Saad

TAVI Case-Club – Alternative access

TAVI Summit - Live case from Berlin

TAVI Case Club – Challenge of difficult access

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

Narcisa's testimonial

TAVI Summit 2023: Aortic stenosis

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

ACC 2023: COAPT™ trial

EuroPCR 2022: TAVI 1yr outcomes

TriClip™ G4: Product overview

TCT 21: EXPAND G4

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: TR – Multileaflet Valve

AV VALVES 2023: Trending Topics – Complexity

Trending Controversies | AV Valves

Case Parade | Mitral focus

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline